A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus

Epstein-Barr virus (EBV) is associated with a range of epithelial and B cell malignancies as well as autoimmune disorders, for which there are still no specific treatments or effective vaccines. Here, we isolate EBV gH/gL-specific antibodies from an EBV-infected individual. One antibody, 1D8, effici...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Qian-Ying, Shan, Sisi, Yu, Jinfang, Peng, Si-Ying, Sun, Cong, Zuo, Yanan, Zhong, Lan-Yi, Yan, Shu-Mei, Zhang, Xiao, Yang, Ziqing, Peng, Yong-Jian, Shi, Xuanling, Cao, Su-Mei, Wang, Xinquan, Zeng, Mu-Sheng, Zhang, Linqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595662/
https://www.ncbi.nlm.nih.gov/pubmed/34785638
http://dx.doi.org/10.1038/s41467-021-26912-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595662/
https://www.ncbi.nlm.nih.gov/pubmed/34785638
http://dx.doi.org/10.1038/s41467-021-26912-6

Ejemplares similares